BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 99 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,056,000 | -72.6% | 1,080,000 | 0.0% | 0.46% | -65.5% |
| Q4 2015 | $11,146,000 | -9.5% | 1,080,000 | 0.0% | 1.33% | -32.2% |
| Q3 2015 | $12,312,000 | +21.3% | 1,080,000 | +58.8% | 1.97% | +45.6% |
| Q2 2015 | $10,152,000 | +65.3% | 680,000 | 0.0% | 1.35% | +42.3% |
| Q1 2015 | $6,140,000 | -36.9% | 680,000 | -15.0% | 0.95% | -36.7% |
| Q4 2014 | $9,728,000 | -9.6% | 800,000 | -27.3% | 1.50% | -32.2% |
| Q3 2014 | $10,758,000 | -27.8% | 1,100,000 | -5.8% | 2.21% | -43.9% |
| Q2 2014 | $14,892,000 | +20.5% | 1,168,000 | 0.0% | 3.95% | +38.9% |
| Q1 2014 | $12,357,000 | +506.6% | 1,168,000 | +335.8% | 2.84% | +380.7% |
| Q4 2013 | $2,037,000 | – | 268,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |